Inho Kim

Author PubWeight™ 49.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res 2008 1.48
2 Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute. Cytotherapy 2010 1.43
3 Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns. Acta Haematol 2017 1.39
4 Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party. Acta Haematol 2014 1.38
5 Calculation of ionization balance and electrical conductivity in nonideal aluminum plasma. Phys Rev E Stat Nonlin Soft Matter Phys 2003 1.38
6 dSet1 is the main H3K4 di- and tri-methyltransferase throughout Drosophila development. Genetics 2011 1.05
7 Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype. Int J Hematol 2009 1.03
8 Chylothorax in Gorham's disease. J Korean Med Sci 2002 1.03
9 Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma. Clin Lymphoma Myeloma 2008 1.02
10 Silicon nanodisk array design for effective light trapping in ultrathin c-Si. Opt Express 2014 0.93
11 Allogeneic bone marrow transplantation in Shwachman-Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med 2002 0.92
12 Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). PLoS One 2008 0.89
13 Clinical dissection of multicentric Castleman disease. Leuk Lymphoma 2011 0.88
14 P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Haematologica 2007 0.88
15 Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol 2011 0.87
16 Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. Br J Haematol 2013 0.87
17 Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib. Ann Hematol 2010 0.86
18 Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide. Eur J Haematol 2014 0.86
19 Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol 2010 0.86
20 Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia. Ann Hematol 2013 0.86
21 Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults. Am J Clin Pathol 2013 0.84
22 Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES. Virology 2003 0.83
23 Short-term memory of TiO2-based electrochemical capacitors: empirical analysis with adoption of a sliding threshold. Nanotechnology 2013 0.83
24 Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation. Am J Hematol 2012 0.82
25 Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study. Ann Hematol 2014 0.82
26 Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia. Korean J Lab Med 2011 0.82
27 Clinical course of non-severe aplastic anemia in adults. Int J Hematol 2010 0.82
28 Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA). Leuk Res 2010 0.81
29 Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood. Mol Cells 2011 0.81
30 Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients. Cancer Chemother Pharmacol 2014 0.81
31 Multiprotocol-induced plasticity in artificial synapses. Nanoscale 2014 0.81
32 Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis. Blood Coagul Fibrinolysis 2013 0.81
33 Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation. Biol Blood Marrow Transplant 2011 0.81
34 Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Ann Hematol 2009 0.80
35 Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Cancer Genet Cytogenet 2010 0.79
36 Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia. Ann Hematol 2010 0.79
37 Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration. Eur J Pharm Biopharm 2006 0.79
38 Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8. Jpn J Clin Oncol 2010 0.79
39 Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation. Clin Transplant 2011 0.79
40 Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma. Am J Hematol 2012 0.78
41 Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center. Hematology 2011 0.78
42 Differential expression profiling of genes in a complete hydatidiform mole using cDNA microarray analysis. Gynecol Oncol 2006 0.78
43 Acute lymphoblastic leukemia in elderly patients: a single institution's experience. Korean J Intern Med 2011 0.78
44 Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Ann Hematol 2009 0.78
45 Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2014 0.78
46 Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report. J Korean Med Sci 2008 0.78
47 Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment. Jpn J Clin Oncol 2010 0.77
48 GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization. Cancer Genet Cytogenet 2010 0.77
49 Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011 0.77
50 Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation. Ann Hematol 2011 0.77
51 RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation. Acta Haematol 2012 0.76
52 Fiber-optic waveguide coupled surface plasmon resonance sensor. Opt Express 2012 0.76
53 DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol 2011 0.76
54 Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Oncol Rep 2009 0.75
55 CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease. Mol Cells 2012 0.75
56 Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission. Korean J Hematol 2010 0.75
57 Cost analysis of iron-related complications in a single institute. Korean J Intern Med 2009 0.75
58 Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation. Korean J Intern Med 2007 0.75
59 Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder. J Korean Med Sci 2010 0.75
60 Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients. Oncol Lett 2010 0.75
61 Induction chemotherapy followed by radiotherapy in the treatment of anal cancer. Oncol Rep 2002 0.75
62 Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation. Clin Transplant 2007 0.75
63 Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thromb Haemost 2014 0.75
64 Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis. Oncol Rep 2013 0.75
65 Elastic resistance change and action potential generation of non-faradaic Pt/TiO2/Pt capacitors. Nanoscale 2013 0.75
66 Catalytic activity for oxygen reduction reaction on platinum-based core-shell nanoparticles: all-electron density functional theory. Nanoscale 2015 0.75
67 Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis. Blood Coagul Fibrinolysis 2016 0.75
68 Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning. Clin Transplant 2014 0.75
69 Novel aspect in grain size control of nanocrystalline diamond film for thin film waveguide mode resonance sensor application. ACS Appl Mater Interfaces 2013 0.75
70 Relaxation oscillator-realized artificial electronic neurons, their responses, and noise. Nanoscale 2016 0.75
71 Synthesis and characterization of SiC nanocomposite catalyst supports with self-formed nanowires. J Nanosci Nanotechnol 2014 0.75
72 Synthesis and characterization of magnesium oxide supported catalysts with a meso-macropore structure. J Nanosci Nanotechnol 2013 0.75
73 Optical design of transparent metal grids for plasmonic absorption enhancement in ultrathin organic solar cells. Opt Express 2013 0.75
74 Thermal damage suppression of a black phosphorus saturable absorber for high-power operation of pulsed fiber lasers. Nanotechnology 2016 0.75